Propel Bio Management »

Cybin Ord shares owned by Propel Bio Management

Quarter-by-quarter ownership of Cybin Ord (CYBN) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Cybin Ord

Tip: Access up to 7 years of quarterly data

All positions including Cybin Ord held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cybin Ord by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $349k 850k 0.41

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Cybin Ord

Point72 Asset Management
Rosalind Advisors
Alyeska Investment Group
PDS Planning
Propel Bio Management
Simplify Asset Management
FNY Investment Advisers
Lewis Asset Management
Virtu Financial
IAG Wealth Partners
BBK Capital Partners
Nadler Financial
Raymond James Financial Services Advisors
Channel Wealth
HPM Partners

View all funds holding Cybin Ord